v3.20.1
Earnings Per Share
 3 Months Ended
Mar. 31, 2020
Earnings Per Share [Abstract]  
Earnings Per Share Earnings Per Share
 
AbbVie grants certain restricted stock units (RSUs) that are considered to be participating securities. Due to the presence of participating securities, AbbVie calculates earnings per share (EPS) using the more dilutive of the treasury stock or the two-class method. For all periods presented, the two-class method was more dilutive.
The following table summarizes the impact of the two-class method:
 
 
Three months ended
March 31,
(in millions, except per share data)
 
2020
 
2019
Basic EPS
 
 
 
 
Net earnings
 
$
3,010

 
$
2,456

Earnings allocated to participating securities
 
14

 
12

Earnings available to common shareholders
 
$
2,996

 
$
2,444

Weighted-average basic shares outstanding
 
1,481

 
1,480

Basic earnings per share
 
$
2.02

 
$
1.65

 
 
 
 
 
Diluted EPS
 
 
 
 
Net earnings
 
$
3,010

 
$
2,456

Earnings allocated to participating securities
 
14

 
12

Earnings available to common shareholders
 
$
2,996

 
$
2,444

Weighted-average shares of common stock outstanding
 
1,481

 
1,480

Effect of dilutive securities
 
3

 
3

Weighted-average diluted shares outstanding
 
1,484

 
1,483

Diluted earnings per share
 
$
2.02

 
$
1.65


Certain shares issuable under stock-based compensation plans were excluded from the computation of EPS because the effect would have been antidilutive. The number of common shares excluded was insignificant for all periods presented.